A phase III randomized trial of high-dose CEOP + filgrastim versus standard-dose CEOP in patients with non-Hodgkin lymphoma: 10-year follow-up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial.
about
Risk of chemotherapy-induced neutropenic complications when treating patients with non-Hodgkin lymphoma.SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disorders.
P2860
A phase III randomized trial of high-dose CEOP + filgrastim versus standard-dose CEOP in patients with non-Hodgkin lymphoma: 10-year follow-up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A phase III randomized trial o ...... homa Group (ALLG) NHL07 trial.
@ast
A phase III randomized trial o ...... homa Group (ALLG) NHL07 trial.
@en
type
label
A phase III randomized trial o ...... homa Group (ALLG) NHL07 trial.
@ast
A phase III randomized trial o ...... homa Group (ALLG) NHL07 trial.
@en
prefLabel
A phase III randomized trial o ...... homa Group (ALLG) NHL07 trial.
@ast
A phase III randomized trial o ...... homa Group (ALLG) NHL07 trial.
@en
P2093
P2860
P356
P1476
A phase III randomized trial o ...... homa Group (ALLG) NHL07 trial.
@en
P2093
Andrew Grigg
Anthony Bonaventura
David Ellis
Ehtesham Abdi
Henry Januszewicz
Jane Palfrey Matthews
Janey Malka Stone
Mark Hertzberg
P2860
P304
P356
10.1002/AJH.23684
P577
2014-02-21T00:00:00Z